Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2008 by University Hospital Tuebingen.
Recruitment status was Recruiting

Sponsor:

Information provided by:

University Hospital Tuebingen

ClinicalTrials.gov Identifier:

NCT00800371

First received: December 1, 2008

Last updated: NA

Last verified: November 2008

History: No changes posted

Tracking Information

First Received Date ^ICMJE

December 1, 2008

Last Updated Date

December 1, 2008

Start Date ^ICMJE

May 2008

Estimated Primary Completion Date

December 2009 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Definition of patients with silent arthritis. [ Time Frame: every three to six months from recruitment to end of study ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Comparison of diagnostic value of MRI and ultrasound. [ Time Frame: every three to six months from recruitment to end of study ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)

Official Title ^ICMJE

Diagnostic Value of MRI and Ultrasound in Patients With JIA

Brief Summary

Juvenile idiopathic arthritis (JIA) may progress asymptomatically leading to joint destruction despite treatment.

The aim of the observational study is to describe patients with silent arthritis comparing symptoms, clinical findings with results of ultrasound and magnetic resonance imaging (MRI).

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Cohort
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Probability Sample

Study Population

Patients with JIA

Condition ^ICMJE

Juvenile Idiopathic Arthritis

Intervention ^ICMJE

Procedure: intra-articular steroid injection

Steroid injection into otherwise noncontrollable arthritis.

Study Group/Cohort (s)

JIA

Patients with JIA

Intervention: Procedure: intra-articular steroid injection

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

Estimated Completion Date

June 2010

Estimated Primary Completion Date

December 2009 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

children without symptoms or with only mild joints swelling or with only minimal limited range of motion

Exclusion Criteria:

patients with manifest arthritis

Gender

Both

Ages

7 Years to 17 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Nikolay Tzaribachev, MD

+49707129 ext 84711

nikolay.tzaribachev@med.uni-tuebingen.de

Location Countries ^ICMJE

Germany

Administrative Information

NCT Number ^ICMJE

NCT00800371

Other Study ID Numbers ^ICMJE

Silent Arthritis PROSPECT 2008

Has Data Monitoring Committee

Responsible Party

Nikolay Tzaribachev, MD, University Children's Hospital

Study Sponsor ^ICMJE

University Hospital Tuebingen

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Nikolay Tzaribachev, MD

University Hospital Tuebingen

Information Provided By

University Hospital Tuebingen

Verification Date

November 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top